Found: 26
Select item for more details and to access through your institution.
Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effects of single and combined immunotherapy approach targeting amyloid β protein and α‐synuclein in a dementia with Lewy bodies–like model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 9, p. 1133, doi. 10.1016/j.jalz.2019.02.002
- By:
- Publication type:
- Article
Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction: TNF-α promotes α-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
TNF-α promotes α-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis.
- Published in:
- Experimental & Molecular Medicine EMM, 2022, v. 54, n. 6, p. 788, doi. 10.1038/s12276-022-00789-x
- By:
- Publication type:
- Article
Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.
- Published in:
- Experimental & Molecular Medicine EMM, 2022, v. 54, n. 4, p. 447, doi. 10.1038/s12276-022-00755-7
- By:
- Publication type:
- Article
Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril.
- Published in:
- Scientific Reports, 2016, p. 30891, doi. 10.1038/srep30891
- By:
- Publication type:
- Article
Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models.
- Published in:
- Frontiers in Neuroscience, 2020, p. 1, doi. 10.3389/fnins.2020.00286
- By:
- Publication type:
- Article
Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03087-7
- By:
- Publication type:
- Article
Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
- Published in:
- PLoS Biology, 2021, v. 19, n. 12, p. 1, doi. 10.1371/journal.pbio.3001480
- By:
- Publication type:
- Article
Neuron-released oligomeric ?-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.
- Published in:
- Nature Communications, 2013, v. 4, n. 3, p. 1562, doi. 10.1038/ncomms2534
- By:
- Publication type:
- Article
Nicotine-mediated effects in neuronal and mouse models of synucleinopathy.
- Published in:
- Frontiers in Neuroscience, 2023, p. 1, doi. 10.3389/fnins.2023.1239009
- By:
- Publication type:
- Article
Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 13, p. 2645, doi. 10.1093/hmg/ddw124
- By:
- Publication type:
- Article
α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 6, p. 1100, doi. 10.1093/hmg/ddv633
- By:
- Publication type:
- Article
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-021-00424-2
- By:
- Publication type:
- Article
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation.
- Published in:
- Nature Communications, 2018, v. 9, p. 1, doi. 10.1038/s41467-018-05958-z
- By:
- Publication type:
- Article
Alpha-synuclein stimulation of astrocytes.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2010, v. 3, n. 4, p. 283, doi. 10.4161/oxim.3.4.12809
- By:
- Publication type:
- Article
Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies.
- Published in:
- Journal of Neuroscience, 2018, v. 38, n. 4, p. 1000, doi. 10.1523/JNEUROSCI.1170-17.2017
- By:
- Publication type:
- Article
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.abq6089
- By:
- Publication type:
- Article
LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 565, p. 1, doi. 10.1126/scitranslmed.aay0399
- By:
- Publication type:
- Article
Retraction Note: Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Controlling the mass action of α-synuclein in Parkinson’s disease.
- Published in:
- Journal of Neurochemistry, 2008, v. 107, n. 2, p. 303, doi. 10.1111/j.1471-4159.2008.05612.x
- By:
- Publication type:
- Article
Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD.
- Published in:
- Molecular Neurodegeneration, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13024-022-00564-6
- By:
- Publication type:
- Article
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.
- Published in:
- Molecular Neurodegeneration, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13024-018-0276-2
- By:
- Publication type:
- Article